DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
当前地点:
>
> This Story


注册记数器 to rate this News Story
Forward Printable StoryPrint Comment

 

 

Business Affairs Homepage

GE Healthcare joins AdvaMed Access to global thought leadership and policy area expertise

Forces driving healthcare M&A activity Understanding why consolidation is going to continue

Boston Scientific to buy VENITI for $160 million Price may rise pending FDA approval of Vici Venous Stent

FDA clears Aidoc AI solution for triaging head CT scans Flags acute intracranial hemorrhage cases by focusing on abnormal regions

Henry Ford Health System and GM enter "Direct to Employer" healthcare contract A first-of-its-kind arrangement for both organizations

Varian to acquire humediQ Global Bringing IDENTIFY automated workflow solution to surface-guided radiation therapy

Brian Tyler McKesson appoints president and chief operating officer

Researchers offer guidance for weighing value in radiology Cost-effective imaging sounds good, but what IS it?

Understanding the cost impact of healthcare consolidation What distinguishes a 'good' merger from a 'bad' one?

Siemens Healthineers to adjust supply networks to minimize tariff hits Expecting 'low single digit million euro impact' on 2018 finances

Sotera Health's Nordion closes sale of medical isotopes business to BWX Technologies

Thomas Dworetzky , Contributing Reporter
Sotera Health has closed its previously-announced sale of Nordion's medical isotopes business to BWX Technologies.

"We are seeing significant growth and new business opportunities for gamma technologies, especially in the exciting new therapeutic applications that are emerging for medical cobalt-60," said Michael Petras, chief executive officer of Sotera Health.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



This sale will let Nordion focus “its full attention on accelerating growth in gamma technologies,” he said in a statement.

The deal gives BWXT Nordion assets including radiochemical and contract manufacturing operations in Kanata, Ontario, and the Vancouver, British Columbia isotope production facility. About 150 employees will be transferred in the deal.

“We are extremely pleased to complete this strategic acquisition,” Rex D. Geveden, BWXT’s president and chief executive officer said in a statement. “With Nordion’s medical isotopes business, we inherit a growing portfolio of radioisotope products. Equally important, we will employ the Nordion medical isotopes team, infrastructural assets and channels to market, to launch our previously announced Mo-99 product line and a number of future radioisotope-based imaging and therapeutic products.”

Tom Burnett, vice president and general manager of BWXT ITG Canada, will lead BWXT’s medical isotopes business. That business will be part of BWXT’s Nuclear Power Group segment, led by John MacQuarrie, president of BWXT Canada.

Nordion will keep its gamma technologies business and its licensed facility in Kanata, with the companies agreeing to a long-term lease deal to let BWXT keep operating from Kanata.

When the deal was announced in April, Dr. Jonathan Cirtain, VP of advanced technologies at BWXT, told HCB News, “We have plans to enter the medical radioisotope market with a new, innovative technology,” adding, “so we feel this is the right time for this acquisition, because we anticipate it will streamline our entry into the industry while mitigating schedule and expense risks associated with new facility construction.”

After closing the deal, BWXT anticipates that it will be able to reduce capital expenditures by about $100 million before acquisition costs. The company expects capital expenditures of approximately $150 million this year.

According to BWXT, this acquisition “accelerates and de-risks” its entry into the medical radioisotope market.

“Anytime a company enters a new business line, certain risks have to be addressed,” said Cirtain. “[The acquisition] adds highly trained personnel, world-class licensed facility assets and decades of experience in the commercial production of radiochemicals and radiopharmaceuticals to BWXT – all of that lowers the risks associated with developing those assets ourselves.

Back to HCB News
  Pages: 1

Business Affairs Homepage


You Must Be Logged In To Post A Comment

做广告
提升您的品牌知名度
拍卖+私人销售
获得最好的价格
买设备/配件
找到最低价格
每日新闻
阅读最新信息
目录
浏览所有的DOTmed用户
DOTmed上的伦理
查看我们的伦理计划
金子分开供营商节目
接收PH要求
金子服务经销商节目
接收请求
提供保健服务者
查看所有的HCP(简称医疗保健提供商)的工具
工作/训练
查找/申请工作
Parts Hunter +EasyPay
获取配件报价
最近证明
查看最近通过认证的用户
最近额定
查看最近通过认证的用户
出租中央
租用设备优惠
卖设备/配件
得到最划算
服务技术员论坛
查找帮助和建议
简单的征求建议书
获取设备报价
真正商业展览
查找对设备的服务
对这个站点的通入和用途是受期限和条件我们支配 法律公告 & 保密性通知
物产和业主对 DOTmed.com,公司 Copyright ©2001-2018 DOTmed.com, Inc.
版权所有